Abstract
Activities as diverse as migration, proliferation and patterning occur simultaneously and in a coordinated fashion during tissue morphogenesis. In the growing vasculature, the formation of motile, invasive and filopodia-carrying endothelial sprouts is balanced with the stabilization of blood-transporting vessels. Here, we show that sprouting endothelial cells in the retina have high rates of VEGF uptake, VEGF receptor endocytosis and turnover. These internalization processes are opposed by atypical protein kinase C activity in more stable and mature vessels. aPKC phosphorylates Dab2, a clathrin-associated sorting protein that, together with the transmembrane protein ephrin-B2 and the cell polarity regulator PAR-3, enables VEGF receptor endocytosis and downstream signal transduction. Accordingly, VEGF receptor internalization and the angiogenic growth of vascular beds are defective in loss-of-function mice lacking key components of this regulatory pathway. Our work uncovers how vessel growth is dynamically controlled by local VEGF receptor endocytosis and the activity of cell polarity proteins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Palamidessi, A. et al. Endocytic trafficking of Rac is required for the spatial restriction of signalling in cell migration. Cell 134, 135–147 (2008).
Le Roy, C. & Wrana, J. L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 6, 112–126 (2005).
Bush, J. O. & Soriano, P. Ephrin-B1 forward signalling regulates craniofacial morphogenesis by controlling cell proliferation across Eph-ephrin boundaries. Genes Dev. 24, 2068–2080 (2010).
Bryant, D. M. & Mostov, K. E. From cells to organs: building polarized tissue. Nat. Rev. Mol. Cell Biol. 9, 887–901 (2008).
Olsson, A. K., Dimberg, A., Kreuger, J. & Claesson-Welsh, L. VEGF receptor signalling—in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359–371 (2006).
Lohela, M., Bry, M., Tammela, T. & Alitalo, K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr. Opin. Cell Biol. 21, 154–165 (2009).
Nilsson, I. et al. VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J. 29, 1377–1388 (2010).
Jakobsson, L. et al. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat. Cell Biol. 12, 943–953 (2010).
Hellstrom, M. et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445, 776–780 (2007).
Benedito, R. et al. The Notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137, 1124–1135 (2009).
Jakobsson, L., Bentley, K. & Gerhardt, H. VEGFRs and Notch: a dynamic collaboration in vascular patterning. Biochem. Soc. Trans. 37, 1233–1236 (2009).
Sawamiphak, S. et al. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 465, 487–491 (2010).
Wang, Y. et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483–486 (2010).
Bochenek, M. L., Dickinson, S., Astin, J. W., Adams, R. H. & Nobes, C. D. Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding. J. Cell Sci. 123, 1235–1246 (2010).
Carmeliet, P., De Smet, F., Loges, S. & Mazzone, M. Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way. Nat. Rev. Clin. Oncol. 6, 315–326 (2009).
Gerhardt, H. et al. VEGF guides angiogenic sprouting using endothelial tip cell filopodia. J. Cell Biol. 161, 1163–1177 (2003).
Traub, L. M. Sorting it out: AP-2 and alternate clathrin adaptors in endocytic cargo selection. J. Cell Biol. 163, 203–208 (2003).
Stone, J. et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15, 4738–4747 (1995).
Tammela, T. et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454, 656–660 (2008).
Benedito, R. et al. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 484, 110–114 (2012).
Bruns, A. F. et al. Ligand-stimulated VEGFR2 signalling is regulated by co-ordinated trafficking and proteolysis. Traffic 11, 161–174 (2010).
Manickam, V. et al. Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6. Blood 117, 1425–1435 (2011).
Meyer, R. D. et al. PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation. Mol. Cell Biol. 31, 2010–2025 (2011).
Makinen, T. et al. PDZ interaction site in ephrinB2 is required for the remodelling of lymphatic vasculature. Genes Dev. 19, 397–410 (2005).
Balklava, Z., Pant, S., Fares, H. & Grant, B. D. Genome-wide analysis identifies a general requirement for polarity proteins in endocytic traffic. Nat. Cell Biol. 9, 1066–1073 (2007).
Nishimura, T. & Kaibuchi, K. Numb controls integrin endocytosis for directional cell migration with aPKC and PAR-3. Dev. Cell 13, 15–28 (2007).
Lee, H. S., Nishanian, T. G., Mood, K., Bong, Y. S. & Daar, I. O. EphrinB1 controls cell–cell junctions through the Par polarity complex. Nat. Cell Biol. 10, 979–986 (2008).
Mishra, S. K. et al. Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor. EMBO J. 21, 4915–4926 (2002).
Joukov, V. et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16, 3898–3911 (1997).
Lanahan, A. A. et al. VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis. Dev. Cell 18, 713–724 (2010).
Zachary, I. & Gliki, G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc. Res. 49, 568–581 (2001).
Friedl, P. & Gilmour, D. Collective cell migration in morphogenesis, regeneration and cancer. Nat. Rev. Mol. Cell Biol. 10, 445–457 (2009).
Suzuki, A. & Ohno, S. The PAR-aPKC system: lessons in polarity. J. Cell Sci. 119, 979–987 (2006).
Goldstein, B. & Macara, I. G. The PAR proteins: fundamental players in animal cell polarization. Dev. Cell 13, 609–622 (2007).
Lampugnani, M. G. et al. CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J. Cell Sci. 123, 1073–1080 (2010).
Iden, S. et al. A distinct PAR complex associates physically with VE-cadherin in vertebrate endothelial cells. EMBO Rep. 7, 1239–1246 (2006).
Titchenell, P. M. et al. Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction. Biochem. J. 446, 455–467 (2012).
Jain, R. K. Molecular regulation of vessel maturation. Nat. Med. 9, 685–693 (2003).
Aranda, V., Nolan, M. E. & Muthuswamy, S. K. Par complex in cancer: a regulator of normal cell polarity joins the dark side. Oncogene 27, 6878–6887 (2008).
Pasquale, E. B. Eph-ephrin bidirectional signalling in physiology and disease. Cell 133, 38–52 (2008).
Martin-Belmonte, F. & Mostov, K. Regulation of cell polarity during epithelial morphogenesis. Curr. Opin. Cell Biol. 20, 227–234 (2008).
Iden, S. & Collard, J. G. Crosstalk between small GTPases and polarity proteins in cell polarization. Nat. Rev. Mol. Cell Biol. 9, 846–859 (2008).
Kim, J. D. et al. Context-dependent proangiogenic function of bone morphogenetic protein signalling is mediated by disabled homolog 2. Dev. Cell 23, 441–448 (2012).
Claxton, S. et al. Efficient, inducible Cre-recombinase activation in vascular endothelium. Genesis 46, 74–80 (2008).
Haigh, J. J. et al. Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signalling. Dev. Biol. 262, 225–241 (2003).
Morris, S. M., Tallquist, M. D., Rock, C. O. & Cooper, J. A. Dual roles for the Dab2 adaptor protein in embryonic development and kidney transport. EMBO J. 21, 1555–1564 (2002).
Hirose, T. et al. PAR3 is essential for cyst-mediated epicardial development by establishing apical cortical domains. Development 133, 1389–1398 (2006).
Hashimoto, N. et al. PKClambda regulates glucose-induced insulin secretion through modulation of gene expression in pancreatic beta cells. J. Clin. Invest. 115, 138–145 (2005).
Wisniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359–362 (2009).
Wisniewski, J. R., Zougman, A. & Mann, M. Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J. Proteome Res. 8, 5674–5678 (2009).
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).
Nakayama, M. et al. Rho-kinase phosphorylates PAR-3 and disrupts PAR complex formation. Dev. Cell 14, 205–215 (2008).
Pitulescu, M. E., Schmidt, I., Benedito, R. & Adams, R. H. Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice. Nat. Protoc. 5, 1518–1534 (2010).
Acknowledgements
We thank K. Ebnet and T. Nishioka for reagents and discussions. The Max Planck Society, the German Research Foundation program SFB 629 (R.H.A.), the EMBO LTF programme, the Japan Society for the Promotion of Science (M.N.), and the US National Institutes of Health (J.A.C) provided funding.
Author information
Authors and Affiliations
Contributions
M.N., K.K. and R.H.A. designed the study. M.N., H.Y., H.C.A.D. and N.I. carried out the identification of ephrin-B2 interacting proteins. M.v.L. purified PAR-3 antibodies and GST-fusion proteins. T.H., S.O., G.B., D.V. and J.A.C. generated mouse mutants or lines. All other experiments were carried out by M.N., A.N. and S.H.; M.N. and R.H.A. wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Information (PDF 3327 kb)
Rights and permissions
About this article
Cite this article
Nakayama, M., Nakayama, A., van Lessen, M. et al. Spatial regulation of VEGF receptor endocytosis in angiogenesis. Nat Cell Biol 15, 249–260 (2013). https://doi.org/10.1038/ncb2679
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb2679
This article is cited by
-
Eph receptors and ephrins in cancer progression
Nature Reviews Cancer (2024)
-
Disable 2, A Versatile Tissue Matrix Multifunctional Scaffold Protein with Multifaceted Signaling: Unveiling Role in Breast Cancer for Therapeutic Revolution
Cell Biochemistry and Biophysics (2024)
-
Disabled-2, a versatile tissue matrix multifunctional scaffold protein with multifaceted signaling: Unveiling its potential in the cancer battle
Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
-
Biology and therapeutic targeting of vascular endothelial growth factor A
Nature Reviews Molecular Cell Biology (2023)
-
KIF13B mediates VEGFR2 recycling to modulate vascular permeability
Cellular and Molecular Life Sciences (2023)